JOHN P. NICHOLSON, M.D.; LAWRENCE M. RESNICK, M.D.; JOHN H. LARAGH, M.D.
Restricting sodium intake is a primary recommendation for patients with hypertension, including those receiving drug treatment. Few studies, however, have examined the impact of different levels of sodium intake on the effectiveness of antihypertensive drugs. We administered two courses of verapamil to 13 patients with essential hypertension during a low-sodium (NaCl, 9 meq/d) and high-sodium (212 meq/d) diet. Overall, verapamil was an effective antihypertensive agent, but expressed its greatest potency in the lower-renin, sodium-sensitive subgroup (change in systolic/diastolic blood pressure, -18.8/-17.7 in sodium-sensitive patients compared with -11.4/ -8.7 in sodium-insensitive patients; p < 0.05). Moreover, the antihypertensive efficacy of verapamil was not blunted by the high-sodium intake. Thus, dietary sodium restriction may not be necessary or appropriate in the treatment of essential hypertension with verapamil; salt-induced cellular calcium uptake may be involved in the phenomenon of sodium sensitivity.
Learn more about subscription options.
Register Now for a free account.
NICHOLSON JP, RESNICK LM, LARAGH JH. The Antihypertensive Effect of Verapamil at Extremes of Dietary Sodium Intake. Ann Intern Med. 1987;107:329–334. doi: 10.7326/0003-4819-107-2-329
Download citation file:
Published: Ann Intern Med. 1987;107(3):329-334.
Cardiology, Coronary Risk Factors, Hypertension, Nephrology, Rhythm Disorders and Devices.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only